Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
Stefan Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 778-787
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
Mark Hamilton, Takeshi Sugio, Troy Noordenbos, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 22, pp. 2047-2060
Open Access | Times Cited: 42
Combined targeted modality in cHL: a risky bet?
Paul J. Bröckelmann, Bastian von Tresckow
Blood (2025) Vol. 145, Iss. 3, pp. 249-251
Closed Access
Computational pathology identifies a low B-cell content in the tumour microenvironment as a predictor of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD
Antonio Santisteban‐Espejo, C. de la Fuente, Alipio Mangas, et al.
Journal of Clinical Pathology (2025), pp. jcp-209848
Closed Access
Classic Hodgkin lymphoma: Pathobiological features that impact emerging therapies
Mohamed Nazem Alibrahim, Annunziata Gloghini, Antonino Carbone
Blood Reviews (2025), pp. 101271-101271
Closed Access
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-12
Closed Access
Future perspectives of fertility protection
Karin Bundschu, S Aleksandrova–Yankulovska, Christian Denzer, et al.
Journal of Reproductive Immunology (2025), pp. 104455-104455
Open Access
Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects
Charles Milrod, Ari Pelcovits, Thomas Ollila
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management
Stephen M. Ansell
American Journal of Hematology (2024)
Closed Access | Times Cited: 4
Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma
Antonio Santisteban‐Espejo, Irene Bernal-Florindo, Pedro Montero‐Pavón, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2457-2457
Open Access | Times Cited: 2
Molecular biomarkers in classic Hodgkin lymphoma
Makoto Kishida, Manabu Fujisawa, Christian Steidl
Seminars in Hematology (2024) Vol. 61, Iss. 4, pp. 221-228
Closed Access | Times Cited: 2
Circulating tumor DNA assisting lymphoma genetic feature profiling and identification
Hongbiao Wang, Zhao Wang, Sujuan Zhu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 4135-4144
Closed Access | Times Cited: 2
Prospects for liquid biopsy approaches in lymphomas
Esraa Jamal, Edward Poynton, Mohamed Elbogdady, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-11
Open Access | Times Cited: 2
Targeted mutational profiling of Epstein Barr virus-positive mucocutaneous ulcer: Implications for differential diagnosis with EBV-positive diffuse large B-cell lymphoma
Ashley K. Volaric, Jyoti Kumar, Veronica Nicholas, et al.
Annals of Diagnostic Pathology (2024) Vol. 73, pp. 152344-152344
Closed Access | Times Cited: 1
Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma
Berit Müller‐Meinhard, Nicole Seifert, Johanna Grund, et al.
HemaSphere (2024) Vol. 8, Iss. 6
Open Access | Times Cited: 1
The Role of Response Adapted Therapy in the Era of Novel Agents
Joseph G. Schroers‐Martin, Ranjana H. Advani
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin Lymphomas
Nadia Withofs, Christophe Bonnet, Roland Hustinx
PET Clinics (2024) Vol. 19, Iss. 4, pp. 447-462
Closed Access | Times Cited: 1
Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Maryam Pourmaleki, Caitlin J. Jones, Sabrina D. Mellinghoff, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3881-3893
Open Access | Times Cited: 1
Hodgkin lymphoma and liquid biopsy: a story to be told
Jesús Velasco-Suelto, Laura Gálvez, Iñaki Comino‐Méndez, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
Jan‐Michel Heger, Laman Mammadova, Julia Mattlener, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 35, pp. 4218-4230
Closed Access | Times Cited: 1
Advances in Hodgkin lymphoma research
Ralf Küppers
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 1
Clinical use of circulating tumor DNA analysis in patients with lymphoma
Bettina Bisig, Karine Lefort, Sylvain Carras, et al.
Human Pathology (2024), pp. 105679-105679
Open Access | Times Cited: 1
Genomic profiling of circulating tumor DNA for childhood cancers
Shaohua Lei, Sujuan Jia, Sunitha Takalkar, et al.
Leukemia (2024)
Closed Access | Times Cited: 1
Cell-Free DNA in Hematologic Malignancies
Joseph G. Schroers‐Martin, Ash A. Alizadeh
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1491-1499
Closed Access | Times Cited: 1
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma
Andrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 826-826
Open Access
Toward a cure for cHL without chemotherapy
Ryan C. Lynch
Blood (2024) Vol. 143, Iss. 9, pp. 741-742
Open Access
Page 1 - Next Page

Scroll to top